BR0313961A - Processos e intermediários para preparar triazolo-piridinas - Google Patents

Processos e intermediários para preparar triazolo-piridinas

Info

Publication number
BR0313961A
BR0313961A BR0313961-1A BR0313961A BR0313961A BR 0313961 A BR0313961 A BR 0313961A BR 0313961 A BR0313961 A BR 0313961A BR 0313961 A BR0313961 A BR 0313961A
Authority
BR
Brazil
Prior art keywords
hydrogen
pyridines
intermediates
processes
alkyl
Prior art date
Application number
BR0313961-1A
Other languages
English (en)
Inventor
Richard Allen Buzon
Michael James Castaldi
Zhengong Bryan Li
David Harold Brown Ripin
Yong Tao
Original Assignee
Pfizer Prod Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc
Publication of BR0313961A publication Critical patent/BR0313961A/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Abstract

"PROCESSOS E INTERMEDIáRIOS PARA PREPARAR TRIAZOLO-PIRIDINAS". A presente invenção refere-se com um novo processo de preparar triazolo-piridinas de fórmula I em que R^ 1^ é selecionado do grupo composto por hidrogênio, (C~ 1~-C~ 6~)alquila ou outros substituintes adequados; R^ 3^ é selecionado do grupo composto por hidrogênio, (C~ 1~-C~ 6~)alquila ou outros substituintes adequados; s é um número inteiro de 0-5; R^ 4^ é hidrogênio ou um substituinte adequado; e com intermediários para a sua preparação. Os compostos preparados de acordo com os métodos da presente invenção são inibidores potentes das cinases MAP, preferencialmente da cinase p38. Aqueles são úteis no tratamento de inflamação, osteoartrite, artrite reumatóide, câncer, reperfusão ou isquemia no acidente vascular cerebral ou ataque cardíaco, doenças auto-imunes e outras perturbações.
BR0313961-1A 2002-08-30 2003-08-18 Processos e intermediários para preparar triazolo-piridinas BR0313961A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US40708502P 2002-08-30 2002-08-30
PCT/IB2003/003669 WO2004020438A2 (en) 2002-08-30 2003-08-18 Novel processes and intermediates for preparing triazolo-pyridines

Publications (1)

Publication Number Publication Date
BR0313961A true BR0313961A (pt) 2005-07-19

Family

ID=31978416

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0313961-1A BR0313961A (pt) 2002-08-30 2003-08-18 Processos e intermediários para preparar triazolo-piridinas

Country Status (10)

Country Link
US (1) US20040053959A1 (pt)
EP (1) EP1537107A2 (pt)
JP (1) JP2006508914A (pt)
AR (1) AR041192A1 (pt)
AU (1) AU2003253188A1 (pt)
BR (1) BR0313961A (pt)
CA (1) CA2496812A1 (pt)
MX (1) MXPA05002123A (pt)
TW (1) TW200413367A (pt)
WO (1) WO2004020438A2 (pt)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004072072A1 (en) * 2003-02-14 2004-08-26 Pfizer Products Inc. Triazolo-pyridines as anti-inflammatory compounds
EP1781655A2 (en) * 2004-08-18 2007-05-09 Pharmacia & Upjohn Company LLC Triazolopyridine compounds useful for the treatment of inflammation
US7579360B2 (en) * 2005-06-09 2009-08-25 Bristol-Myers Squibb Company Triazolopyridine 11-beta hydroxysteroid dehydrogenase type I inhibitors
US7572807B2 (en) * 2005-06-09 2009-08-11 Bristol-Myers Squibb Company Heteroaryl 11-beta-hydroxysteroid dehydrogenase type I inhibitors
TW200817410A (en) 2006-08-07 2008-04-16 Incyte Corp Triazolotriazines as kinase inhibitors
ES2301380B1 (es) 2006-08-09 2009-06-08 Laboratorios Almirall S.A. Nuevos derivados de 1,7-naftiridina.
GEP20125658B (en) 2006-11-22 2012-10-10 Incyte Corp Imidazotriazines and imidazo pyrimidines as kinase inhibitors
ES2320955B1 (es) 2007-03-02 2010-03-16 Laboratorios Almirall S.A. Nuevos derivados de 3-((1,2,4)triazolo(4,3-a)piridin-7-il)benzamida.
ES2329639B1 (es) 2007-04-26 2010-09-23 Laboratorios Almirall S.A. Nuevos derivados de 4,8-difenilpoliazanaftaleno.
EP1992344A1 (en) 2007-05-18 2008-11-19 Institut Curie P38 alpha as a therapeutic target in pathologies linked to FGFR3 mutation
US8119658B2 (en) 2007-10-01 2012-02-21 Bristol-Myers Squibb Company Triazolopyridine 11-beta hydroxysteroid dehydrogenase type I inhibitors
EP2108641A1 (en) 2008-04-11 2009-10-14 Laboratorios Almirall, S.A. New substituted spiro[cycloalkyl-1,3'-indo]-2'(1'H)-one derivatives and their use as p38 mitogen-activated kinase inhibitors
EP2113503A1 (en) 2008-04-28 2009-11-04 Laboratorios Almirall, S.A. New substituted indolin-2-one derivatives and their use as p39 mitogen-activated kinase inhibitors
HUE034716T2 (hu) 2008-05-21 2018-02-28 Incyte Holdings Corp 2-Fluor-N-metil-4-[7-(kinolin-6-il-metil)-imidazo[1,2-b][1,2,4]triazin-2-il]benzamid sói és eljárások ezek elõállítására
EP2322176A1 (en) 2009-11-11 2011-05-18 Almirall, S.A. New 7-phenyl-[1,2,4]triazolo[4,3-a]pyridin-3(2H)-one derivatives
JP5714030B2 (ja) 2010-02-03 2015-05-07 インサイト コーポレーションＩｎｃｙｔｅ Ｃｏｒｐｏｒａｔｉｏｎ Ｃ−Ｍｅｔ阻害剤としてのイミダゾ［１，２−ｂ］［１，２，４］トリアジン
JP5957526B2 (ja) 2011-09-15 2016-07-27 ノバルティス アーゲー チロシンキナーゼとしての６−置換３−（キノリン−６−イルチオ）−［１，２，４］トリアゾロ［４，３−ａ］ピラジン
CA3128468A1 (en) 2017-10-05 2019-04-11 Fulcrum Therapeutics, Inc. P38 kinase inhibitors reduce dux4 and downstream gene expression for the treatment of fshd
US10342786B2 (en) 2017-10-05 2019-07-09 Fulcrum Therapeutics, Inc. P38 kinase inhibitors reduce DUX4 and downstream gene expression for the treatment of FSHD
WO2024054476A1 (en) * 2022-09-09 2024-03-14 Fmc Corporation New processes for synthesis of (3-chloro-2-pyridyl)hydrazine

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69433501T2 (de) * 1993-11-08 2004-11-04 Smithkline Beecham Corp. Oxazole zur behandlung von zytokinvermittelten erkrankungen
ES2205167T3 (es) * 1996-01-11 2004-05-01 Smithkline Beecham Corporation Nuevos compuestos de imidazol sustituidos.
US6207687B1 (en) * 1998-07-31 2001-03-27 Merck & Co., Inc. Substituted imidazoles having cytokine inhibitory activity
US6469018B1 (en) * 1999-01-08 2002-10-22 Smithkline Beecham Corporation Compounds
CO5170501A1 (es) * 1999-04-14 2002-06-27 Novartis Ag AZOLES SUSTITUIDOS UTILES PARA EL TRATAMIENTO DE ENFERMEDADES MEDIADAS POR TNFa eIL-1 Y ENFERMEDADES DEL METABOLISMO OSEO
OA12552A (en) * 2001-03-09 2006-06-06 Pfizer Prod Inc Triazolopyridines as anti-inflammatory agents.

Also Published As

Publication number Publication date
EP1537107A2 (en) 2005-06-08
AU2003253188A1 (en) 2004-03-19
AU2003253188A8 (en) 2004-03-19
WO2004020438A3 (en) 2004-07-22
JP2006508914A (ja) 2006-03-16
CA2496812A1 (en) 2004-03-11
WO2004020438A2 (en) 2004-03-11
MXPA05002123A (es) 2005-06-06
US20040053959A1 (en) 2004-03-18
AR041192A1 (es) 2005-05-04
TW200413367A (en) 2004-08-01

Similar Documents

Publication Publication Date Title
BR0313961A (pt) Processos e intermediários para preparar triazolo-piridinas
AP2002002463A0 (en) Novel triazolo-pyrimides anti-inflammatory compounds.
BR0201087A (pt) Compostos antiinflamatórios de benzotriazol
DOP2002000349A (es) Nuevos compuestos antiinflamatorios de bencimidazol
BR0204588A (pt) Derivados de n-alquil-adamantil-triazinil-benzamida
HUP0100394A2 (hu) 2-es Helyzetben fenil-szubsztituenst hordozó imidazo-triazinon-származékok, eljárás előállításukra és ezeket tartalmazó gyógyszerkészítmények
CA2304713A1 (en) Biphenyl-5-alkanoic acid derivatives and use thereof
BR0215622A (pt) Inibidores da dpiv com base em glutaminila
BRPI0408369A (pt) derivados de indol úteis para o tratamento de doenças
Pugh et al. Inhibition of newcastle disease virion messenger RNA (guanine-7-)-methyltransferase by analogs of S-adenosylhomocysteine
BR0109457A (pt) Composto, composição farmacêutica,método de preparação de composições farmacêuticas, processo para prepapação de compostos, e, métodos de tratamento de distúrbios psiquiátricos, de distúrbios gastrointestinais e de distúrbios cardiovasculares
WO2002092573A3 (en) Heterocyclic substituted pyrazoles as inhibitors of src and other protein kinases
MXPA05008568A (es) Nuevos compuestos anti-inflamatorios triazolo-piridinas.
BR0015718A (pt) Quinazolinas e seu uso para inibição de enzimas de cinase dependente de ciclina
EP1725536B8 (en) Imidazoline derivatives having cb1-antagonistic activity
HUP0401987A2 (hu) A triazolil-imidazopiridin és a triazolilpurin vegyületek adenozin-a2A-receptorligandumként használható származékai és gyógyszerként történő alkalmazásuk
BR0313965A (pt) Compostos antiiflamatórios di e triflúor-triazolo-piridinas
BRPI0410391A (pt) derivados (2-hidróxi-2-(4-hidróxi-3-hidroximetilfenil)-etilamino)- propilfenila como agonistas beta2
BRPI0414059A (pt) sìntese seletiva de pirimidinas substituìdas em cf3
PT865498E (pt) Processo para a preparacao de ciclodepsipeptideos com 24 atomos no anel substituidos contendo acido aril-lactico
DK165744C (da) Thienopyrimidinderivater, fremgangsmaader til fremstilling deraf og farmaceutiske praeparater
WO2002014281A8 (en) Pyridine derivatives as inhibitors of p38
DK0862577T3 (da) Sulfamatderivater af 1,3,5(10)-estratrien-derivater, fremgangsmåde til deres fremstilling og farmaceutiske præparater, der
IL93892A (en) N-) Phenyl Alkyl (Purine-6-Amines and N-) Phenylalkyl (-H1-Pirazolo] D-3,4 [Pyrimidine-4 Amines and selective pharmacological preparations for adenosine receptor containing or
GEP19991710B (en) Hydroxy-Nitrogen Containing-Heterocyclic-Carbon Acids, Microbiological Methods for Its Production, Microoganism Strain Ki 101 (D5M 6920)

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 4A,5A,6A E 7A ANUIDADES.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2069 DE 31/08/2010.